Loading search results

Outcome Measures

Primary Outcomes (1)

Time of intubation
Success rate of Time of intubation
Up to 24 hours

Secondary Outcomes (4)

Advancing the endotracheal tube over the bronchoscope
Up to 24 hours
Percentage of success of endotracheal tube insertion
Up to 24 hours
Removal of the bronchoscope
Up to 24 hours
Complications
Up to 24 hours

Study Arms (2)

Group A

ACTIVE COMPARATOR

The Ovassapian Fibreoptic Intubating Airway has a flat lingual surface that widens distally. This provides better retraction of the tongue to prevent it and the soft tissues of the anterior pharyngeal wall from herniating around the side of the airway. The airway has a pair of vertical sidewalls and two pairs of curved guide walls at its proximal section. These walls are separated by a gap which allows removal of the airway after intubation has been completed

Device: Ovassapian Fibreoptic Intubating Airway

Group B

ACTIVE COMPARATOR

Fekry airway: ● It has two parts are: Airway body\& Special connector 1. Airway body consists of: 1. Flange → it is the buccal end it is 7 cm wide to prevent it from 2. moving deeper into mouth \& may also serve to fix airway in place. 3. Bite Portion → it is straight \& fits between teeth \&oral cavity. 4. Oral straight part → open anterior lingual part; it varies in length according to size 5. Pharyngeal curved part → extends backwards to correspond the shape oropharynx and ends below laryngeal inlet. 2. The connector: it is a special type (two sizes: adult and pediatric) can attach to all ventilating machines\& it has a teeth rest act as a bite block.

Interventions

Ovassapian Fibreoptic Intubating AirwayDevice

The fibreoptic bronchoscope remains one of the most important methods of intubating patients particularly when there is difficulty with intubation.Facilitating fiberoptic oropharyngeal intubation procedure, specific airways have been devised to push the tongue anteriorly to clear a passage for the fibrescope into the trachea. Of these airways Ovassapian Fibreoptic Intubating Airway (Kendall, Argyle, New York, New York, USA) and Fekry Oral Intubating Airway (Ameco Tech, Cairo, Egypt).

Also known as: Fekry airway

Group AGroup B

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Study Design

Study Type

interventional

Phase

not applicable

Allocation

RANDOMIZED

Masking

DOUBLE

Who Masked

PARTICIPANT, INVESTIGATOR

Masking Details

Randomization will be done using computer generated number and concealed using sequentially numbered, sealed opaque envelope.

Purpose

DIAGNOSTIC

Intervention Model

PARALLEL

Model Details: Either the Fekry Oral Airway Intubator (Ameco Tech, Cairo, Egypt) or the Ovassapian Fibreoptic Intubating Airway (Kendall Sheridan, Argyle, NY) will be inserted into the mouth in random order, and the patient's lungs ventilated by bag and facemask with 100% oxygen and 1-1.5% isoflurane. Blinding will be impossible in this study as the operator has to see the airway through the fibrescope in order to perform the assessment. After confirmation of full neuromuscular blockade, a bronchoscope with a preloaded tracheal tube will be then inserted through the airway for bronchoscopic assessment.

Sponsor Type

OTHER

Responsible Party

PRINCIPAL INVESTIGATOR

PI Title

Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University

Comparison of the Fekry Oral Intubating Airway and Ovassapian Fibreoptic Intubating Airway for Fibreoptic Orotracheal Intubation

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations